Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 24, 2024

SELL
$1.14 - $2.09 $254,607 - $466,780
-223,340 Closed
0 $0
Q4 2021

Apr 24, 2024

BUY
$1.67 - $2.76 $222,945 - $368,460
133,500 Added 148.6%
223,340 $436 Million
Q3 2021

Apr 24, 2024

BUY
$2.62 - $3.45 $235,380 - $309,948
89,840 New
89,840 $246 Million

Others Institutions Holding VTGN

About VistaGen Therapeutics, Inc.


  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $637M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Bulltick Wealth Management, LLC Portfolio

Follow Bulltick Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bulltick Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bulltick Wealth Management, LLC with notifications on news.